Keyphrases
10 Steps
10%
Absorbed Dose
10%
Activity Distribution
10%
Albumin
10%
Ascites
10%
Bilirubin
10%
Biological Effective Dose
40%
Bremsstrahlung
10%
Characteristic-based
10%
Coefficient of Variation
10%
Confidence Interval
10%
Contrast-enhanced Computed Tomography
10%
D100
10%
Discrete-time Markovian Arrival Process (D-MAP)
10%
Dose Heterogeneity
20%
Dose Metrics
20%
Dose Volume
10%
Dose-response
100%
Dose-response Curve
10%
Glass Microspheres
100%
Health Response
10%
Hepatocellular Carcinoma
100%
Liver
10%
Local Deposition
10%
Logistic Regression Model
10%
Magnetic Resonance Imaging Scan
10%
Mann-Whitney U Test
10%
Modified RECIST
30%
Modified Response Evaluation Criteria in Solid Tumors (mRECIST)
10%
Negative Predictive Value
10%
No Complication
10%
Non-responders
20%
Normal Liver
30%
Objective Response Rate
10%
Organizational Assessment
10%
Patient Cohort
10%
Positive Predictive Value
10%
RECIST Criteria
10%
Response Characteristics
10%
Response Evaluation Criteria in Solid Tumors (RECIST)
30%
Response Status
10%
Single-photon Emission Computed Tomography (SPECT)
100%
Threshold Dose
10%
Tumor
100%
Tumor Response
30%
Tumor Size
10%
Tumor Volume
10%
Univariate Logistic Regression
10%
Volume Coverage
10%
Voxel Dosimetry
100%
World Health Organization
30%
Yttrium-90 Radioembolization
100%
Medicine and Dentistry
Absorbed Dose
7%
Ascites
7%
Bilirubin
7%
Computer Assisted Tomography
7%
Dose Response
100%
Dosimetry
100%
Hepatocellular Carcinoma
100%
Logistic Regression Analysis
7%
Magnetic Resonance Imaging
7%
Microsphere
100%
Neoplasm
100%
Pyrazinamide
14%
Radioembolization
100%
Rank Sum Test
7%
Response Evaluation Criteria in Solid Tumors
28%
Single Photon Emission Computed Tomography-Computed Tomography
100%
Yttrium 90
100%
Pharmacology, Toxicology and Pharmaceutical Science
Ascites
7%
Bilirubin
7%
Dosimetry
100%
Liver Cell Carcinoma
100%
Microsphere
100%
Neoplasm
100%
Pyrazinamide
14%
Solid Malignant Neoplasm
28%
Yttrium 90
100%